Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Big 4 Drug Wholesalers Raided on Bid-Rigging Charges
November 28, 2019
- Ono Files Tirabrutinib for Add’l Indications in Japan
November 28, 2019
- Ono Seeks to Add 4-Week Dosing to Opdivo Monotherapy
November 28, 2019
- Chugai to End Joint Venture with South Korea's JW Pharma
November 28, 2019
- Chugai Launches Tecentriq 840 mg for Triple-Negative Breast Cancer
November 28, 2019
- ASKA’s Oral Hysteromyoma Drug Shows Non-Inferiority to Leuprorelin in PIII
November 28, 2019
- Sumitomo Dainippon to Launch Global Data Design Office, Leveraging Roivant’s Technology
November 28, 2019
- Otsuka Completes Construction of New Plant in Tokushima
November 28, 2019
- Japan’s First Biosimilars for Nesp, Forteo Hit Shelves
November 27, 2019
- Hisamitsu’s Osteoarthritis Patch Drug Delivers Positive PII Data; PIII Launch Planned in FY2020
November 27, 2019
- Astellas Pharma Grabs China Approval for Xtandi
November 27, 2019
- Kyowa Kirin, Ardelyx Bolster Partnership with Additional Research Deal, US$20 Million Equity Investment
November 27, 2019
- Asahi Kasei to Buy Veloxis for 143.2 Billion Yen, Eyes US Transplant Market
November 26, 2019
- Takeda Set to Pursue 4-Way Global Development, Hails China’s Market Potential
November 26, 2019
- No Need for Acquisitions over Next 5 Years, 12 NMEs to Counter Patent Cliff: Takeda CEO
November 26, 2019
- Takeda’s ALK Drug Yield Positive Update in 1st Line NSCLC
November 26, 2019
- Xofluza Now Available in Taiwan: Shionogi
November 26, 2019
- AnGes to Initiate US Clinical Study for Collategene in Arteriosclerosis Obliterans Patients with Lower Limb Ulcers
November 26, 2019
- Asahi Kasei Pharma Licenses Fasudil to Woolsey; Development of Oral Formulation Expected
November 26, 2019
- Keio Univ. Spin-Off Raises 2.8 Billion Yen to Develop Regenerative Medicine Products for Heart Failure
November 26, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…